// App-Quantinova.ai

57 : Investigating the prognostic value of TP53 and PIK3CA mutations in metastatic colorectal cancer (mCRC): Applying Structured Query Language (SQL) algorithms to real-world data from a high-volume U.K. tertiary cancer center.

Researchers

Presenter

  • Caroline Fong

Principal Investigators

  • Ali Abdulnabi Mohamed

  • Geraldo Alves de Paula Neto

  • Marion Teare

  • Elli Bourmpaki

  • Clare Peckitt

  • David J. Watkins

  • Sheela Rao

  • Naureen Starling

  • Ian Chau

  • David Cunningham

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Cluster of Differentiation 206

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

  • Tumor protein p53

  • DNA mismatch repair status

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved